Preeclampsia Severe Clinical Trial
Official title:
Preeclampsia And Nonsteroidal Drugs for Analgesia (PANDA): a Randomized Non Inferiority Trial
A randomized non-inferiority trial of women with preeclampsia with severe features to determine if the addition of nonsteroidal anti-inflammatory drugs is inferior or non-inferior to standard analgesic bundles in their impact on postpartum hypertension.
Recently published clinical guidelines for the care of women with hypertensive disorders recommended that nonsteroidal anti-inflammatory drugs (NSAIDs) should be withheld from patients with hypertension that persists for more than one day postpartum (1). This recommendation is based in data from the general medicine literature, which suggests a role of NSAIDs in precipitating hypertension in non-pregnant adults (2,3). It may also draw from previously published case reports of post-partum hypertension that were thought to be NSAID induced (4). There has been a paucity of data from the obstetric literature to support or rebuff this recommendation. As the opioid crisis worsens in the United States, additional attention and resources have focused on limiting the use of narcotic medications. The effective employment of non-opioid analgesics has been shown to reduce narcotic use (5). Ibuprofen and other NSAIDs are the most effective and most commonly prescribed analgesics for postpartum pain, but clinicians now find themselves stuck between these recommendations and their efforts to limit unnecessary opioid prescriptions. The investigators propose a randomized controlled non-inferiority trial of women with preeclampsia comparing a postpartum analgesic protocol that includes NSAIDs, to one that excludes them. The central hypothesis is that NSAID use does not worsen hypertensive diseases of pregnancy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04243278 -
Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)
|
Early Phase 1 | |
| Not yet recruiting |
NCT03318211 -
Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial
|
Phase 4 | |
| Completed |
NCT05594056 -
Transorbital Ultrasound of Optic Nerve Sheath Diameter Between Healthy Pregnant Women and Those With Severe Preeclampsia.
|
N/A | |
| Recruiting |
NCT03761888 -
Nicardipine and Labetalol Effects on Cerebral Hemodynamics in Preeclampsia
|
||
| Not yet recruiting |
NCT06373367 -
Preeclampsia Educational Program Study (PrEPS)
|
N/A | |
| Not yet recruiting |
NCT04855513 -
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
|
N/A | |
| Not yet recruiting |
NCT05232994 -
Metformin and Esomeprazole For Preterm Pre-eclampsia
|
Phase 1 | |
| Completed |
NCT04392375 -
Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor
|
Phase 4 | |
| Completed |
NCT04236258 -
Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
|
Phase 4 | |
| Completed |
NCT04756661 -
Uterotonics for Severe Preeclampsia
|
N/A | |
| Active, not recruiting |
NCT04660032 -
Nudge to Drive Transitions of Care
|
N/A | |
| Completed |
NCT04103489 -
The Use of Eculizumab in HELLP Syndrome
|
Phase 1 | |
| Enrolling by invitation |
NCT04794855 -
Risk Prediction Model of Preeclampsia
|
||
| Recruiting |
NCT04311749 -
Expanded NIPT for Pregnancy Complications
|
||
| Active, not recruiting |
NCT06359015 -
Metformin and Esomeprazole in Preterm Pre-eclampsia
|
Phase 4 | |
| Recruiting |
NCT05610774 -
Optic Nerve Sheath Diameter in Pre-Eclamptic Parturient Receiving Magnesium Sulfate Combined With Dexmedetomidine
|
N/A | |
| Completed |
NCT03815110 -
Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification
|
||
| Completed |
NCT03210350 -
Effect of Magnesium Sulphate on the Intracranial Pressure of Preeclamptic Patients
|
||
| Completed |
NCT03451266 -
Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia
|
Phase 1 | |
| Active, not recruiting |
NCT06360601 -
Intravenous Labetalol Versus Hydralazine in Preeclampsia
|
Phase 1/Phase 2 |